MedPath

Patients Response in Laparoscopic Gynaecological Surgeries Following Instillation Of Levo-Bupivacaine Intraperitoneally

Not Applicable
Completed
Conditions
Health Condition 1: D279- Benign neoplasm of unspecified ovaryHealth Condition 2: N809- Endometriosis, unspecifiedHealth Condition 3: D251- Intramural leiomyoma of uterusHealth Condition 4: N925- Other specified irregular menstruation
Registration Number
CTRI/2019/07/020152
Lead Sponsor
DR ASIF MUSTAFA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

The study will include ASA-I &II women presenting to Max Smart super specialty Hospital Saket for elective laparoscopic Gynecological surgery meeting the inclusion criteria as described below:

1) ASA I &II patients.

2) Age 18-70yrs.

3) elective surgery

Exclusion Criteria

The study will include ASA-I &II women presenting to Max Smart super specialty Hospital Saket for elective laparoscopic Gynecological surgery with exclusion criteria as described below:

1) ASA III and above patients

2) Use of opioids within 24hrs prior to study

3) Drugs & alcohol abuse

3) History of allergy to any drug used in study.

4) Patients having chronic pain syndrome

5) Treatment with steroids prior to surgery

6) Patient with diagnostic laparoscopy without surgical procedure.

7) Patients who do not understand VAS pain scale.

8) Patients not willing to be included in the study- not giving consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate whether instillation of levo-bupivacaine intraperitoneal decreases post operative pain after laparoscopic gynecological surgeries, using VAS pain Scale.Timepoint: 24 HOURS POST SURGERY
Secondary Outcome Measures
NameTimeMethod
1.To assess requirement of rescue analgesia in post operative periods.Timepoint: Hourly till 24 Hours Post Surgery;2.To assess whether the incidence of PONV (post operative nausea and vomiting) reduces in the study group. <br/ ><br>Timepoint: 24 HOURS POST SURGERY
© Copyright 2025. All Rights Reserved by MedPath